The cost of emulated target trials: Is real‐world data cheaper than randomized studies?
The authors declare no conflicts of interest. Dr. Barosa reports receiving grants from the Luso-American Development Foundation (FLAD) during the conduct of the study. Dr. Prasad reports receiving grants from Arnold Ventures Research funding during the conduct of the study; royalties from Johns Hopkins Press, Medscape and MedPage; consulting fees from UnitedHealthcare and OptumRx; subscription revenue from YouTube, Patreon and Substack outside the submitted work. No other disclosures were reported. The data that support the findings of this study are available from the corresponding author upon reasonable request. Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Vinay Prasad (ORCID: https://orcid.org/0000-0002-6110-8221)
- Mariana Barosa (ORCID: https://orcid.org/0000-0001-7729-448X)
Institutions
- University of Lisbon (PT)
- University of California, San Francisco (US)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1111/eci.70035
- Citations
- 3
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 9.39
Funders
- Arnold Ventures
- Fundação Luso-Americana para o Desenvolvimento